Transarterial chemoembolisation is not superior to embolisation alone: The recent European Association for the Study of the Liver (EASL)–European Organisation for Research and Treatment of Cancer (EORTC) guidelines-Reference-Cited by-同舟云学术

Transarterial chemoembolisation is not superior to embolisation alone: The recent European Association for the Study of the Liver (EASL)–European Organisation for Research and Treatment of Cancer (EORTC) guidelines

Published:2013-04 Issue:6 Volume:49 Page:1509-1510
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Tsochatzis Emmanuel,Meyer Tim,O’Beirne James,Burroughs Andrew K.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference9 articles.

1. Management of hepatocellular carcinoma;EASL–EORTC clinical practice guidelines;Eur J Cancer,2012

2. Which transarterial therapy is best for hepatocellular carcinoma? – the evidence to date;Tsochatzis;J Hepatol,2010

3. Hepatocellular carcinoma;Tsochatzis;N Engl J Med,2012

4. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment;Tsochatzis;Semin Oncol,2010

5. Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma;Oliveri;Cochrane Database Syst Rev,2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ten-eleven translocation-2-mediated macrophage activation promotes liver regeneration;Cell Communication and Signaling;2024-02-02

2. Cyclin B2 overexpression promotes tumour growth by regulating jagged 1 in hepatocellular carcinoma;Aging;2022-03-29

3. Development of a tRNA-derived small RNA diagnostic and prognostic signature in liver cancer;Genes & Diseases;2022-03

4. Study on the Expression of TOP2A in Hepatocellular Carcinoma and Its Relationship with Prognosis;Advances in Clinical Medicine;2022

5. Efficacy and safety of various primary treatment strategies for very early and early hepatocellular carcinoma: a network meta-analysis;Cancer Cell International;2021-12